Trials / Completed
CompletedNCT06337981
Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients
A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AJU-S56 in Patients With Dry Eye Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- AJU Pharm Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study is planned to Evaluate the Efficacy and Safety of test drug (AJU-S56) compared to control drug(vehicle) in Patients with Dry Eye Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | (AJU-S56 5% and placebo) | (AJU-S56 5%) and placebo(Vehicle), 1drop/1times, 3times in a day |
| DRUG | AJU-S56 5% | (AJU-S56 5%), 1drop/1times, 6times in a day |
| DRUG | Placebo(Vehicle) | Placebo(Vehicle), 1drop/1times, 6times in a day |
Timeline
- Start date
- 2021-11-22
- Primary completion
- 2022-06-14
- Completion
- 2022-11-28
- First posted
- 2024-03-29
- Last updated
- 2024-04-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06337981. Inclusion in this directory is not an endorsement.